RespireRx Pharmaceuticals Inc (CE) (RSPI) News

I think we’ll be pleasantly surprised sooner v later. “Trading” in limbo on EM is a huge hindrance in my book to attract parters, talent, investors, etc. it becomes an unwanted tarnished reflection.

This pipeline of horses are at the starting gate. Bets are placed. Time for these stallions to run free..

IF ANYONE IS DUMB ENOUGH OR WORRIED WITH PRIVATE TAKE A LOOK AT LINK BELOW

https://www.secform4.com/insider-trading/849636.htm

Insiders own almost 30 percent of the o/s. Limited shares available. No way they go
Private they would clearly pocket less money.

If you have a position sub 003 average consider yourself fortunate. This will run big once back on market and any funding is released minimum 02 run before consolidation period then once further news hits 05 and above.

This won’t pay up in 1-2 months but 6-18 months we all looking at 10-20x

It’s what people with absolutely no life do. He’s miserable so he wants others to be miserable as well. He cannot stand the idea that anyone might strike it rich on one of these.

I am sure the straggling bashers here just want to see noteholders and shareholders sell out their equity positions at whatever price.

% of Shares owned = % of shares of these assets whether they trade on EM, OTC or Nasdaq or even as a private enterprise.

Once they figure out additional funding and structure to support grant funding programs and DOD funded SCI trials this will reemerge and launch back into public trading at much higher valuations.

There is a reason all stakeholders aligned with equity positions and preferred/executives require huge payment events to unlock additional equity. Certainly trading on the EM for peanuts while bashers light up your investment message board is not one of those reasons..

Why do you care if people lose money in this stock isn't there another stock or investment you can make money in?

Hey look, another clueless RSPI shareholder. You might want to do some actual DD on the topic because you have no clue what you are talking about. Those so called warrants are a thing of the past. They are no longer valid. The debt is secured with shares of stock. Noteholders were issued shares of stock with a PAR value of .0001. Again the only option for shareholders and or Noteholders is to sell at whatever the current market value is. RSPI CEO made a brilliant move letting the stock go to the Expert Market. It cleared the path for them to go private.

Agree. There is no trading liquidity. There is a reason this board is being constantly read and visited by doomsayers.

Must be significant value in any abandoned shares that can be loosened.

Anyone with half a brain can apply logic and surmise what is likely ongoing in the background here. IMO they got the goods.

Agree. There is no trading liquidity. There is a reason this board is being constantly read and visited by doomsayers.

Must be significant value in any abandoned shares that can be loosened.

Anyone with half a brain can apply logic and surmise what is likely ongoing in the background here. IMO they got the goods.

There are many stakeholders here. Insiders and executives with warrants and loans outstanding. Convertible debt holders. Institutional. Medical Centers, partners/providers, DOD/NIH have supported. They are looking for new funding sources. This future success of company/ROI for stakeholders requires liquidity. Going private makes zero sense.

Now maybe there is some tax advantage or such to transition company to a different exchange or part of M&A/funding agreements by having current value of peanuts vs properly valuing company in the 10s if not 100 million range. Who knows.

You aren't very bright are you? Why would he tell a shareholder his plans to go private? Obviously you know nothing about trading or even business for that matter. If he told you anything that was not already public or even hinted at it he would be in violation of Reg-FD. Any information he gives a shareholder that is not already public would be considered insider information. Learn how trading works...

Thanks for the tip jeoff

I swear I thought u were clowning us for using maybe scenarios lol. Look at you now talking about private non sense which has never been mentioned before. I even asked Jeff no hint or indication was received. So take your dumb opinions and lock it your room in your moms basement bum.

Please move to Canada and keep buying. - Jeff

The only reason a CEO would allow their company to be placed on the Expert Market is if they wanted the price to tank. Most shareholders only have the option to sell. It doesn't take a rocket scientist to see this company is going private and shareholders are getting screwed. By moving to the EM management and insiders are assured no new shareholders can purchase shares. They know as time passes bag holders will eventually sell at .0001 for a tax loss. The only ones that can buy are out of the US so that gives the company and its insiders the opportunity to repurchase ALL the outstanding shares at deep discount without having to make an offer to shareholder to buy them out.

Shareholders would not accept a buyout offer of .0001 per share but by the company going to the EM they have no other options. The company can buy back all the shares for less than $100k now. If they made an offer to shareholders to buy them out that price would be much higher


Authorized Shares
2,000,000,000
07/22/2024
Outstanding Shares
936,463,730

So again you talk about money. All you are doing is proving to the board you are butt hurt over your investment decisions. People who actually have money do not brag about it or try and belittle those who do not have it. You are not fooling anyone.

I ain’t reading all that from a person poorer than me.
Looks like brokie talk. Poor people like to talk a lot of game to hide their empty pockets. Get ur money up lil kid or stfu.

Actually people with skin in the game are here. Naysayers with no stake are just rodents destined to be driven over and remembered as roadkill.

The OTC Markets has identified specific circumstances in which a Caveat Emptor designation is assigned.  Once assigned, more often than not, it is not removed.  The circumstances are set forth below.

Promotion/Spam Without Adequate Current Information

The security is being promoted to the public, but adequate current information about the company has not been made available to the public.

Investigation of Fraud or Other Criminal Activities

OTC Markets Group becomes aware of an investigation of fraudulent or other criminal activity involving the company, its securities, or insiders.

Suspension/Halt

A regulatory authority or an exchange has halted or suspended trading for public interest concerns (i.e., not a news or earnings halt).

Undisclosed Corporate Actions

The security or company is the subject of a corporate action, such as a reverse merger, stock split, or name change, without adequate current information being publicly available.

Unsolicited Quotes

The security has only been quoted on an unsolicited basis since it entered the public markets, and the company has not made adequate current information available to the public.

Other Public Interest Concern

OTC Markets Group has determined that there is a public interest concern regarding security.  Such concerns may include but are not limited to promotion, spam, or disruptive corporate actions even when adequate current information is available.

I can imagine A.I. being utilized to accelerate the development of candidate drug compounds and such. In the end however, A.I. can only predict and understand based upon inputs from the human experiences programming such. I think it will be a very long time before A.I. will have enough confidence to predict drug impacts on humans without going through rigorous human clinicals. Too many unknowns and risks that investors, patients, doctors, etc will not tolerate.

Overall definitely another tool to accelerate advancements in society.

In doing research on artificial intelligence the one guy out of the two or three in the world that most people interview for informed perspective on the matter says there's a machine that can set on top of the desk and you can ask questions of it as an artificial intelligence device as to what would happen chemically if you combine X Y and Z for instance in other words it's it's a chemistry laboratory with all the knowledge human beings have of chemistry without the beakers and the actual liquids and professors and show on. And supposedly this is a reality now that many people in medical science are using a shortcuts and then of course if the AI machine says hey here's a combination that will cure cancer then the human beings rushed to an actual laboratory and repeat the experiment or test out them the solution Advanced by artificial intelligence. But what it does is it helps to clear the pathway forward as to what might be efficacious and what might not be efficacious since the computers can take all the knowledge and from what I understand do trillions of operations per second whereas in the recent past it's only been able to do billions of operations per sec. So with all of this computational Statistics which makes up artificial intelligence according to Patrick Henry Winston got arrested Soul who was in charge of the artificial intelligence Department in MIT for 25 years and who is not afraid of it because he said well it's intelligent she did not see it attaining Consciousness the ability to feel pain and so forth. It just seems that the people during the medical science nrspi have to have available to them the most modern technological advancements in artificial intelligence to help refine strategically the direction they take with their experiments and you just have to have that kind of knowledge and experience of a Dr LIPA to be able to forge a strategic path forward with artificial intelligence compared to being a Lewis and Clark who know how to explore but going into Virgin Territory and kind of Meandering their way through with what expertise they have to offer. In the end with the Advent and exponential increase in artificial intelligence is going to take people with integrity and values like Dr LIPA to associate with other people like Dr Lipa to get quality and not Shams and scams in the area of Medical Science in particularly pharmaceuticals?

"the other side"...

In my opinion.... will come sooner than later. With these assets moving into human clinicals and the massive potential of their pipeline it becomes delicate that they are conducting all business activitities with integrity or they open the door to all kinds of headaches down the road as well as loss of opportunity. The silence on all matters and allowing their stock to now move to the EM speaks volumes.

Stakeholders including recent institutional, debt holders, executives, industry & medical center partnerships and even us little long retail investors are clearly watching how they move all this forward. Stakeholder minimal expectations would be to have the company positioned to capitalize and execute on DOD funding moving SCI drug into phase 2 and NIH grant potential for KRM-ll-81 successfully exiting NIH preclinicals into human trials as well as all the effort and partners setting up the OSA program in Australia and moving that program forward.

Just absolutely huge potential across the board, yet here the corporation is now situated trading under 1 million in valuation in an illiquid public trading platform. I would not expect this abberation to last that long as again this along with all the silence begs a significant slew of questions amongst stakeholders and frankly probably amongst future stakeholders as well. I suppose many of us have a "make this make sense" thought rolling around in our heads...

That's because a lot of bag holders got trapped on the last pump and dump. This stock is worthless because the company is going private.

On the off note even in EM we are top 5 in breakout boards lol. Even with this is out of commission eyes still carefully watching

Right on RSPI

For the short-term it sucks being on the Expert Market! I have faith in this investment 100% that we will do very well on the other side of this.

Agree. I am guessing they are looking for support long term from sophisticated, professional and institutional investors and not otc traders.

No matter how many pr or 8k he releases pps not gona pop because u.sa traders can't buy in EM market

I believe several of their scientists as well as the VP businessman they brought in late last year have histories with Lilly.

Maybe is meaningless or possibly meaningful as several pipeline endeavors overlap a bit.

I tend to agree and RSPI probably looking for that scenario more around phase 2/3 clinicals when success will yield many multiples more in value compared with current exiting preclinicals successfully.

However, with pharmaceutical industry flush with cash one could imagine BP possibly interested in some equity stake as part of a funding round. If the pipeline assets potentially fit their company, a smallish risk/investment now could really payoff when time comes to purchase a drug asset!

I would guess many possible paths of funding on the table.

I think Lilly buyout if it does happen will be far into the future, a situation which hinges upon many variables.

Still even with the current developments which I believe will be lucrative for us investors if we’re being honest we’re still fairly early in the process of actually pharmaceutical usage of their drug.

They will need some kinda of fda approval before any sort of buyout is discussed or worked on. And for fda backing many more hoops need to be jumped through.

The two 2024 publications that I posted both had Lippa and Cerne as authors. I have more than 80 publications in high tier journals (i.e., I know a lot about science/publishing). Many of these medical journals have three reviewers, all of whom are highly respected in their fields. Cerne works for Eli Lilly. He participated in the research and writing of those papers in order to be an author. So, Eli Lilly paid, at least to some extent, the research and perhaps the publication fee. Possible scenario: Lippa left Eli Lilly to develop the few prospects in the RSPI pipeline using funds from stock sales and grants, thus saving development funds. Under this possible scenario, when will Lilly buy out RSPI?

Quote He did say tho 8-k’s will keep coming even in EM

Correct

He can’t give one one one advice. That’s insider trading. He did say tho 8-k’s will keep coming even in EM. Also stated his experience in the auditing nature of companies, as he spent 28 years in investment banking. Also reaffirmed his vested interest in the well being of the company as he holds a considerable amount of shares in it.

When I asked was it blander on the company management that we are approaching EM? He responded by redirecting the question to the top half of the 8-k saying that the ATT deal is a huge step to find avenues in funding. Also said only otc traders are concerned with short term price. I found what he said after to be really ironic, ‘trading otc on the day to day is a dangerous game.’

We should be extremely blessed to get a Buyout news. In reality very hard for BO to happen just like that. For some reason I have great Faith in this Management / Team. Hopefully they will make all the right moves. Good luck to all.

Cool thanks for letting us know bro!

Even if it was a after hours buy should see it posted on lv2 but I don’t. Unless it was so small like 1 share it slipped right through

I don't know doesn't show.

Ok. Error maybe. Sorry I thought he joking

He said it was a after hours trade

What was the share count buy?

RefreshJul 24, 2024, 4:32 PM ET
Over The Counter Market
RSPI RESPIRERX PHARMACEUTICALS INC COM
$0.0003 0.000 (0.00%)
Extended hours
$0.00265 +0.00235 (+783.33%)

Now up 1000%🤪

It's day time now....why u dreaming??

Price 0.0026

Don’t see any trades went through on ihub

What price?

RSPI after hour trading is up 783% on etrade!!!!

Been waiting everyday! I feel aging!

Em market isn’t really bad, as long as stock isn’t regulated to caveat expert. Should be relatively easy to jump back into the exchange. Only caveat expert is a coffin sentence

His LinkedIn says he left his position of Principal Research Scientist at Eli Lilly in Mar. 2018.

So many people cannot, at their present level of knowledge, engage in talking with Dr. Lippa or others of his educational and experiential esteem, that to give a true update to retail investors such as we, would require too much time away from achieving productive gain in the medical science they are pursuing?

It would cost more money to hire someone to write:

'RSPI FOR DUMMIES' ?

Lippa is also coauthor. RSPI likely has a connection to Eli Lilly.